Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polyclonal long-term repopulating stem cell clones in a primate model.
Schmidt M, Zickler P, Hoffmann G, Haas S, Wissler M, Muessig A, Tisdale JF, Kuramoto K, Andrews RG, Wu T, Kiem HP, Dunbar CE, von Kalle C. Schmidt M, et al. Among authors: muessig a. Blood. 2002 Oct 15;100(8):2737-43. doi: 10.1182/blood-2002-02-0407. Blood. 2002. PMID: 12351380 Free article.
A model for the detection of clonality in marked hematopoietic stem cells.
Schmidt M, Glimm H, Lemke N, Muessig A, Speckmann C, Haas S, Zickler P, Hoffmann G, Von Kalle C. Schmidt M, et al. Among authors: muessig a. Ann N Y Acad Sci. 2001 Jun;938:146-55; discussion 155-6. doi: 10.1111/j.1749-6632.2001.tb03584.x. Ann N Y Acad Sci. 2001. PMID: 11458502
A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.
Penack O, Fischer L, Stroux A, Gentilini C, Nogai A, Muessig A, Ganepola S, Lange T, Kliem C, Marinets O, Blau IW, Thiel E, Uhareka L. Penack O, et al. Among authors: muessig a. Int J Hematol. 2007 May;85(4):326-32. doi: 10.1532/IJH97.E0622. Int J Hematol. 2007. PMID: 17483077 Clinical Trial.
Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation.
Penack O, Fischer L, Stroux A, Gentilini C, Nogai A, Muessig A, Rieger K, Ganepola S, Herr W, Meyer RG, Thiel E, Uharek L. Penack O, et al. Among authors: muessig a. Bone Marrow Transplant. 2008 Feb;41(4):377-83. doi: 10.1038/sj.bmt.1705911. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982494